Dynamic Technology Lab Private LTD Gossamer Bio, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.74 - $12.87 $8,940 - $66,126	5,138 Added 17.86%	33,911 $74,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $207,453 - $428,142	28,773 New	28,773 $345,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $207,453 - $428,142	28,773 New	28,773 $345,000
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $145,393 - $242,809	-24,354 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $205,547 - $304,181	24,354 New	24,354 $211,000
Q2 2021 Aug 13, 2021	SELL	$8.0 - $9.75 $143,784 - $175,236	-17,973 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$8.63 - $10.94 $19,529 - $24,757	-2,263 Reduced 11.18%	17,973 $166,000
Q4 2020 Feb 11, 2021	BUY	$8.3 - $13.59 $167,958 - $275,007	20,236 New	20,236 $196,000

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.